270 related articles for article (PubMed ID: 38167030)
41. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
Jin S; Li X; Dai Y; Li C; Wang D
Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
[TBL] [Abstract][Full Text] [Related]
42. Anticancer effects of veratramine via the phosphatidylinositol-3-kinase/serine-threonine kinase/mechanistic target of rapamycin and its downstream signaling pathways in human glioblastoma cell lines.
Kim D; Kwon W; Park S; Kim W; Park JK; Han JE; Cho GJ; Yun S; Han SH; Kim MO; Ryoo ZY; Choi SK
Life Sci; 2022 Jan; 288():120170. PubMed ID: 34826438
[TBL] [Abstract][Full Text] [Related]
43. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
44. Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway.
Wu L; Zhang G; Zhu Q; Huang Y
J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583438
[TBL] [Abstract][Full Text] [Related]
45. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
Xiong W; Li D; Ao F; Tu Z; Xiong J
Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
[TBL] [Abstract][Full Text] [Related]
46. Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.
Song W; Zhao H; Cui Z; Ma X; Zhang W; Wang D; Liu A; Yuan L
Tumour Biol; 2016 Nov; 37(11):15229-15240. PubMed ID: 27686608
[TBL] [Abstract][Full Text] [Related]
47. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
Ding H; Cui L; Wang C
Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Fang D; Lai Z; Wang Y
Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
[TBL] [Abstract][Full Text] [Related]
50. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA
Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890
[TBL] [Abstract][Full Text] [Related]
51. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.
Hwang SK; Baker AR; Young MR; Colburn NH
Carcinogenesis; 2014 Jul; 35(7):1469-80. PubMed ID: 24413684
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA miR-212 regulates PDCD4 to attenuate Aβ
Wang Y; Chang Q
Biotechnol Lett; 2020 Sep; 42(9):1789-1797. PubMed ID: 32474742
[TBL] [Abstract][Full Text] [Related]
53. Corin protects H
Li Y; Xia J; Jiang N; Xian Y; Ju H; Wei Y; Zhang X
Biomed Pharmacother; 2018 Jan; 97():594-599. PubMed ID: 29101802
[TBL] [Abstract][Full Text] [Related]
54. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of
Jiang H; Su Z; Hu W; Yuan X; Yu T; Yang J; Xiao X; Zheng S; Lin B
OMICS; 2023 May; 27(5):215-226. PubMed ID: 37196148
[TBL] [Abstract][Full Text] [Related]
55. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.
Liu C; Wu H; Li Y; Shen L; Yu R; Yin H; Sun T; Sun C; Zhou Y; Du Z
J Neurooncol; 2017 Nov; 135(2):263-272. PubMed ID: 28887597
[TBL] [Abstract][Full Text] [Related]
56. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
57. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
58. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
[TBL] [Abstract][Full Text] [Related]
59. lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K/Akt/NF-
Jia H; Yan X
Biomed Res Int; 2022; 2022():3729069. PubMed ID: 35860793
[TBL] [Abstract][Full Text] [Related]
60. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]